Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
229 studies found for:    Open Studies | "Glaucoma"
Show Display Options
Rank Status Study
21 Unknown  Corneal Endothelium After Glaucoma Surgery
Conditions: Glaucoma;   Corneal Damage;   Intraocular Pressure
Intervention:
22 Recruiting Subjects With Open-angle Glaucoma, Pseudoexfoliative Glaucoma, or Ocular Hypertension Naïve to Medical and Surgical Therapy, Treated With Two Trabecular Micro-bypass Stents (iStent Inject) or Travoprost
Condition: Open-angle Glaucoma
Interventions: Device: iStent inject;   Drug: Travoprost
23 Unknown  Comparison Between Deep Sclerectomy and Traditional Trabeculotomy & Trabeculectomy in Congenital Glaucoma
Condition: Congenital Glaucoma
Interventions: Procedure: Deep Sclerectomy;   Procedure: Combined Trab
24 Recruiting SYL040012, Treatment for Open Angle Glaucoma
Conditions: Open Angle Glaucoma;   Ocular Hypertension
Interventions: Drug: 1 drop of SYL040012 (bamosiran) Dose A;   Drug: 1 drop of SYL040012 (bamosiran) Dose B;   Drug: 1 drop of SYL040012 (bamosiran) Dose C;   Drug: 1 drop of SYL040012 (bamosiran) Dose D;   Drug: 1 drop of timolol maleate
25 Recruiting Safety and Efficacy of One, Two, or Three iStents for the Reduction of Intraocular Pressure in Open-angle Glaucoma Subjects
Condition: Primary Open Angle Glaucoma (POAG)
Intervention: Device: iStent
26 Unknown  Prevalence of Glaucoma in the Israeli Arab Population
Condition: Glaucoma
Intervention:
27 Unknown  Risk Factors for Glaucoma in Musicians
Condition: Glaucoma
Intervention:
28 Unknown  Glaucoma Treatment by Cyclo-coagulation Using High Intensity Focused Ultrasound (HIFU)
Condition: Glaucoma
Intervention: Device: EYEOP1
29 Unknown  Subconjunctival Bevacizumab to Prevent Bleb Failure After Glaucoma Filtration Surgery
Condition: Glaucoma
Intervention: Drug: Subconjunctival Bevacizumab
30 Unknown  Ahmed Valve Glaucoma Implant With Adjunctive Subconjunctival Bevacizumab in Refractory Glaucoma
Condition: Refractory Glaucoma
Interventions: Drug: Subconjunctival Avastin;   Device: Ahmed Valve implant
31 Recruiting Micropulse Laser Trabeculoplasty Versus Selective Laser Trabeculoplasty for Treatment of Open Angle Glaucoma
Condition: Open Angle Glaucoma
Interventions: Device: Micropulse Laser Trabeculoplasty;   Device: Selective Laser Trabeculoplasty
32 Unknown  Efficacy of Retinal Nerve Fiber Layer (RNFL) / Retinal Thickness Ratio by Cirrus OCT Utilizing Spectral -Domain Technology as a Diagnostic Predictor of Glaucoma
Conditions: Glaucoma;   Myopia
Intervention:
33 Unknown  Trabectome Versus Trabeculectomy With Mitomycin C in Patients With Open Angle Glaucoma
Condition: Open Angle Glaucoma
Interventions: Procedure: Trabectome +/- Cataract Surgery;   Procedure: Trabeculectomy with Mitomycin C +/- Cataract Surgery
34 Unknown  The Genetic Characteristics in South Korean Patients With Primary Congenital Glaucoma
Condition: Primary Congenital Glaucoma
Intervention:
35 Recruiting Open-Angle Glaucoma Subjects With One Prior Trabeculectomy Treated Concurrently With One Suprachoroidal Stent and Two Trabecular Micro-bypass Stents
Condition: Open-Angle Glaucoma
Intervention: Device: iStent and iStent supra
36 Unknown  Instrument for Glaucoma Early Detection and Monitoring
Condition: Glaucoma
Intervention: Device: Glaucoma Diagnosis, Name: Neucodia
37 Recruiting Ocular Blood Flow Assessment in Glaucoma
Condition: Glaucoma
Intervention: Other: Flow imaging
38 Recruiting Myocilin Variations and Familial Glaucoma in Taxiarchis
Condition: Glaucoma
Intervention:
39 Recruiting Drinking Habits of Glaucoma Patients and Age Matched Controls
Conditions: Dehydration;   Glaucoma
Intervention: Behavioral: alter drinking habits
40 Recruiting A Phase 1/2 Multicenter, Randomized, Study to Evaluate the Safety and Efficacy of VS101 Subconjunctival Latanoprost Insert in Subjects With Open-Angle Glaucoma or Ocular Hypertension
Conditions: Open Angle Glaucoma;   Ocular Hypertension
Interventions: Drug: VS101 Insert Dose A;   Drug: VS101 Insert Dose B;   Drug: VS101 Insert Dose C;   Drug: Latanoprost 0.005% eye drops

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years